4.5 Article

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2016 EXECUTIVE SUMMARY

期刊

ENDOCRINE PRACTICE
卷 22, 期 9, 页码 1111-1118

出版社

AMER ASSOC CLINICAL ENDOCRINOLOGISTS
DOI: 10.4158/EP161435.ESGL

关键词

-

资金

  1. Amgen Inc
  2. NPS Pharmaceuticals
  3. NASA-JSC
  4. Amgen
  5. Merck
  6. Eli Lilly and Company
  7. Opko Health
  8. Novartis
  9. GE Healthcare Lunar
  10. NPS Pharmaceuticals, Inc.
  11. Gilead Sciences
  12. Radius Health
  13. AgNovos
  14. Radius Pharma
  15. Roche
  16. Ultragenyx
  17. Alexion
  18. Boehringer Ingelheim
  19. Immunodiagnostics
  20. Merck Serrano
  21. National Bone Health Alliance
  22. Roche Diagnostics
  23. Regeneron
  24. Daiichi Sankyo
  25. Elsevier
  26. Cystic Fibrosis Foundation
  27. NIH
  28. Sanofi
  29. Sprout
  30. Editorial Board for the Harvard Health Letter
  31. Metrowest Medical Center
  32. Beth Israel Deaconess Medical Center, Needham
  33. Beth Israel Deaconess Medical Center, Boston
  34. Boston University Dental School and Medical School
  35. MCE Conferences
  36. Celgene Corporation

向作者/读者索取更多资源

The American Association of Clinical Endocrinologists/American College of Endocrinology Medical Guidelines for Practice are systematically developed statements to assist healthcare professionals in medical decision-making for specific clinical conditions. Most of the content herein is based on literature reviews. In areas of uncertainty, professional judgment was applied. These guidelines are a working document that reflects the state of the field at the time of publication. Because rapid changes in this area are expected, periodic revisions are inevitable. We encourage medical professionals to use this information in conjunction with their best clinical judgment. The presented recommendations may not be appropriate in all situations. Any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Urology & Nephrology

Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings From a Randomized Trial

Alayne D. Markland, Camille P. Vaughan, Alison J. Huang, Eunjung Kim, Vadim Y. Bubes, Vin Tangpricha, Julie R. Buring, I-Min Lee, Nancy R. Cook, JoAnn E. Manson, Francine Grodstein

Summary: The purpose of this study was to evaluate the effectiveness of vitamin D supplementation in preventing or treating overactive bladder and urinary incontinence in men. The results showed that overall, vitamin D supplementation did not improve overactive bladder or urinary incontinence compared to placebo. However, there were inconsistent findings when vitamin D supplements were used in men with lower levels of 25-hydroxyvitamin D.

JOURNAL OF UROLOGY (2023)

Article Urology & Nephrology

Family Planning and Fertility Counseling Perspectives of Gender Diverse Adults and Youth Pursuing or Receiving Gender Affirming Hormone Therapy

Eric Walton, Sina Abhari, Vin Tangpricha, Cameron Futral, Akanksha Mehta

Summary: This study investigated family planning and fertility counseling perspectives of reproductive-age gender diverse adults and youth pursuing gender affirming hormone therapy. The results showed that individuals interested in or uncertain about future parenthood were more likely to consider cryopreservation and report inadequate family planning counseling. Therefore, current counseling practices may be insufficient and referral to a fertility specialist should be considered.

UROLOGY (2023)

Review Endocrinology & Metabolism

Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review

Renata Arrington-Sanders, Nathan T. Connell, Devin Coon, Nadia Dowshen, Anna L. Goldman, Zil Goldstein, Frances Grimstad, Noelle Marie Javier, Ellie Kim, Martina Murphy, Tonia Poteat, Asa Radix, Aviva Schwartz, Colt St Amand, Carl G. Streed Jr, Vin Tangpricha, Mabel Toribio, Robert H. Goldstein

Summary: Gender affirming hormone therapy (GAHT) improves mental health outcomes in transgender persons, but the risk of venous thromboembolism (VTE) should be considered, especially during long-term therapy and perioperative period. Hormone formulation, dosing, route, and duration of therapy can impact thromboembolic risk, and individualized risk assessment is necessary to avoid stopping GAHT due to concerns about VTE risk.

ENDOCRINE PRACTICE (2023)

Editorial Material Endocrinology & Metabolism

Message from the Editor in Chief of Endocrine Practice: Celebrating 28 Years!

Vin Tangpricha

ENDOCRINE PRACTICE (2023)

Article Public, Environmental & Occupational Health

Prevalence of self-inflicted injuries among transgender and gender diverse adolescents and young adults compared to their peers: an examination of interaction with mental health morbidity

Sanjana Pampati, W. Dana Flanders, Qi Zhang, Brian K. Ahmedani, Shalender Bhasin, Darios Getahun, Timothy L. Lash, Courtney McCracken, David E. Sandberg, Michael J. Silverberg, Vin Tangpricha, Suma Vupputuri, Michael Goodman

Summary: Comparison between self-inflicted injuries among transgender and gender diverse (TGD) youth and their cisgender peers reveals that TGD individuals are more likely to engage in self-harm and have multiple mental health diagnoses. Universal suicide prevention efforts are necessary for all youth, including those without mental health issues, with intensified efforts for TGD youth and those with mental health diagnoses.

ANNALS OF EPIDEMIOLOGY (2023)

Article Endocrinology & Metabolism

Incidence and Factors Associated With Acne in Transgender Adolescents on Testosterone: A Retrospective Cohort Study

Lena Chu, Sarah Gold, Carlyn Harris, Leslie Lawley, Pranav Gupta, Vin Tangpricha, Michael Goodman, Howa Yeung

Summary: This retrospective cohort study aimed to assess the incidence and predictors of acne among transgender adolescents receiving testosterone. It found that 54% of the patients who did not have baseline acne developed acne within 1 year of testosterone initiation. Patients who used progestin prior to or during follow-up were more likely to develop acne. Therefore, transgender adolescents starting testosterone, particularly those taking progestin, should be monitored for acne development and treated proactively.

ENDOCRINE PRACTICE (2023)

Correction Nutrition & Dietetics

The effect of a single, large bolus of vitamin D in healthy adults over the winter and following year: a randomized, double-blind, placebo-controlled trial (vol 69, pg 193, 2015)

M. D. Kearns, J. N. G. Binongo, D. Watson, J. A. Alvarez, D. Lodin, T. R. Ziegler, V. Tangpricha

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2023)

Article Endocrinology & Metabolism

Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study

Pranav Gupta, Briana C. Patterson, Lena Chu, Sarah Gold, Seth Amos, Howa Yeung, Michael Goodman, Vin Tangpricha

Summary: This study investigated the proportion and reasons for discontinuation of gender-affirming hormone therapy (GAHT) in transgender and gender diverse (TGD) individuals. The results showed that only a small percentage of participants discontinued GAHT, and the main reason was achieving desired treatment effects. This suggests that GAHT discontinuation is low when therapy follows the guidelines of the Endocrine Society.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Urology & Nephrology

Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults

Meron Siira, Darios Getahun, Michael J. Silverberg, Vin Tangpricha, Michael Goodman, Howa Yeung

Summary: This study examined patient satisfaction with current gender-affirming hormone therapy and their goals for additional hormone therapy. The majority of participants were satisfied with their current therapy, but transfeminine individuals and older participants were less likely to report satisfaction. Transfeminine individuals were more likely to plan for additional treatment to achieve goals such as breast size growth and feminine body fat distribution, while transmasculine individuals aimed for reducing dysphoria and masculine body fat distribution.

JOURNAL OF SEXUAL MEDICINE (2023)

Article Computer Science, Information Systems

Validation of an administrative algorithm for transgender and gender diverse persons against self-report data in electronic health records

Carl G. Streed Jr, Dana King, Chris Grasso, Sari L. Reisner, Kenneth H. Mayer, Guneet K. Jasuja, Tonia Poteat, Monica Mukherjee, Ayelet Shapira-Daniels, Howard Cabral, Vin Tangpricha, Michael K. Paasche-Orlow, Emelia J. Benjamin

Summary: The study aims to validate an algorithm for identifying transgender and gender diverse (TGD) patients within electronic health record (EHR) data and evaluate its accuracy. The algorithm was validated in an EHR data set with self-reported gender identity using TGD-related diagnosis and procedure codes, and hormone therapy prescription data. The results showed that the algorithm had good sensitivity, specificity, positive predictive value, and negative predictive value in identifying TGD patients in administrative data. Further categorization based on prescription data also had high accuracy.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2023)

Article Endocrinology & Metabolism

Changes in bone turnover after high-dose vitamin D supplementation during acute pulmonary exacerbation in cystic fibrosis

Malinda Wu, Anirudh Bhimavarapu, Jessica A. Alvarez, William R. Hunt, Vin Tangpricha

Summary: People with cystic fibrosis have increased risk for low bone mineral density and CF-related bone disease due to chronic inflammation and infection. This study suggests that vitamin D supplementation during acute pulmonary exacerbation may help reduce the risk for CF-related bone disease by decreasing markers of bone turnover.
Article Endocrinology & Metabolism

Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized Study

E. Michael Lewiecki, Edward Czerwinski, Chris Recknor, Anna Strzelecka, Guillermo Valenzuela, Mary Lawrence, Stuart Silverman, Jose Cardona, Susan M. Nattrass, Neil Binkley, Miriam Annett, Leny Pearman, Bruce Mitlak

Summary: This study evaluated the safety and efficacy of the abaloparatide microstructured transdermal system (abaloparatide-sMTS) as an alternative to subcutaneous injection. The results showed that the abaloparatide-sMTS was not noninferior to the subcutaneous injection in terms of lumbar spine bone density at 12 months, but both treatments significantly increased lumbar spine and total hip bone density.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Review Endocrinology & Metabolism

Proceedings of the 2023 Santa Fe bone symposium: Progress and controversies in the management of patients with skeletal diseases

E. Michael Lewiecki, Teresita Bellido, John P. Bilezikian, Jacques P. Brown, Azeez Farooki, Christopher S. Kovacs, Brendan Lee, William D. Leslie, Michael R. McClung, Mark L. Prasarn, Deborah E. Sellmeyer

Summary: The 23rd annual Santa Fe Bone Symposium brought together attendees from various states and countries to discuss topics related to osteoporosis and other bone diseases. The event included plenary presentations, panel discussions, workshops, and oral presentations of research abstracts.

JOURNAL OF CLINICAL DENSITOMETRY (2023)

Correction Multidisciplinary Sciences

Author Correction: Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD) (vol 13, 8617, 2023)

Pichatorn Suppakitjanusant, Nittaya Kasemkosin, Alisa K. Sivapiromrat, Samuel Weinstein, Boonsong Ongphiphadhanakul, William R. Hunt, Viranuj Sueblinvong, Vin Tangpricha

SCIENTIFIC REPORTS (2023)

Article Psychology, Clinical

Prevalence of Psoriasis and Perceived Association with Hormone Therapy in Transgender Adults

Hayley Braun, Elaine C. Thompson, Qi Zhang, Vin Tangpricha, Michael Goodman, Howa Yeung

Summary: The prevalence of psoriasis among transgender individuals is similar to that in the general population, but further longitudinal research is needed to explore the potential association between psoriasis and gender-affirming hormone therapy.

TRANSGENDER HEALTH (2023)

暂无数据